BLRX


These 2 Penny Stocks Could Rally All the Way to $11, Say Analysts

At its January FOMC meeting, the Federal Reserve held interest rates steady – they are near rock-bottom now, and to no one’s surprise, …

BioLineRx Pops 34% On ‘Positive’ Results From Cancer Stem Cell Trial

Shares of BioLineRx Ltd. skyrocketed 34% on Oct.

3 “Strong Buy” Biotech Stocks Under $5 With Explosive Upside Potential

Which stocks are leading the pack out on Wall Street? Biotechs.

Why BioLineRx (BLRX) Stock Spiked Today

A journey of a thousand miles begins with a single step, and a big one in this case. BioLineRx (BLRX) announced this morning that …

3 Small Cap Biotechs with Upcoming Catalysts

Written by Danny Cohen of stockmatusow.com BiolineRx (BLRX) is slated to report on complete data at the European Society for Medical Oncology (ESMO) …

Stock Update (NASDAQ:BLRX): Bioline RX Ltd Sets in Motion Phase 3 Trial for Stem Cell Mobilization Therapy BL-8040

Bioline RX Ltd (NASDAQ:BLRX) is officially turning its Phase 3 GENESES clinical trial’s wheels, with the Israeli drug maker revealing today the launch …

Stock Update (NASDAQ:BLRX): Bioline RX Ltd to Get Another Direct $9.6 Million from Its Largest Shareholder Company

Bioline RX Ltd (NASDAQ:BLRX) announced that BVF Partners L.P.

Bioline RX Ltd (BLRX) Shares Tumble on Announcement of Underwritten Public Offering

Bioline RX Ltd (NASDAQ:BLRX) investors are heading for the hills after the the drug maker announced that it has commenced an underwritten public offering …

Company Update (NASDAQ:BLRX): Bioline RX Ltd Provides Update on Phase 2 Open-Label Study for BL-8040 as Novel Stem Cell Mobilization Treatment

Bioline RX Ltd (NASDAQ:BLRX) reported partial results data from its open-label Phase 2 trial for BL-8040 as a novel monotherapy approach for the …

Stock Update (NASDAQ:BLRX): Here’s Why Bioline RX Ltd Shares Soaring 11%

Bioline RX Ltd (NASDAQ:BLRX) gave investors reason for excitement today after announcing the initiation of a second Phase 2a trial investigating BL-8040 in combination …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts